New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
Ara Metjian1, Charles S Abrams21Department of Medicine, Duke University Medical Center, Durham, NC, USA; 2Department of Medicine, University of Pennsylvania, Philadelphia, PA, USAAbstract: Decades of basic science and clinical research have led to an increased understanding of the pathophysiology of...
Enregistré dans:
Auteurs principaux: | Ara Metjian, Charles S Abrams |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/74cf4975d3a343f5966897488f73a8f1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
par: Barış YILMAZ, et autres
Publié: (2021) -
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
par: Lawrence Rice
Publié: (2009) -
Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura
par: Aicha Laghmouchi, et autres
Publié: (2021) -
Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle
par: Andreas Rank, et autres
Publié: (2010) -
THROMBOTIC THROMBOCYTOPENIC PURPURA: OUR CLINICAL EXPERIENCE
par: Zahid Farooq Baig, et autres
Publié: (2018)